BFS Molecular Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

BFS Molecular General Information

Description

Developer of molecular diagnostics software intended to transform the way post-transplantation patient care is practiced. The company provides post-transplant monitoring tests, using the latest NGS - Next Generation Sequencing technology on the reliable and scalable Illumina platforms as well as offers novel approaches and quality results, helping physicians with early detection of transplant rejection or disease relapse.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Strada Sportului 13A
  • Corbeanca, Ilfov
  • Tamasi, 077068
  • Romania
Primary Industry
Outcome Management (Healthcare)
Acquirer
Corporate Office
  • Strada Sportului 13A
  • Corbeanca, Ilfov
  • Tamasi, 077068
  • Romania

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BFS Molecular Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore BFS Molecular‘s full profile, request access.

Request a free trial

BFS Molecular Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of molecular diagnostics software intended to transform the way post-transplantation patient care is practiced
Outcome Management (Healthcare)
Tamasi, Romania

Pittsburgh, PA
 

Cambridge, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

BFS Molecular Competitors (17)

One of BFS Molecular’s 17 competitors is Ariel(Decision/Risk Analysis), a Venture Capital-Backed company based in Pittsburgh, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ariel(Decision/Risk Analysis) Venture Capital-Backed Pittsburgh, PA
Congenica Venture Capital-Backed Cambridge, United Kingdom
PierianDx Private Equity-Backed Creve Coeur, MO
Fabric Genomics Venture Capital-Backed Oakland, CA
GenoSpace Corporate Backed or Acquired Cambridge, MA
You’re viewing 5 of 17 competitors. Get the full list »

BFS Molecular FAQs

  • When was BFS Molecular founded?

    BFS Molecular was founded in 2017.

  • Where is BFS Molecular headquartered?

    BFS Molecular is headquartered in Tamasi, Romania.

  • What industry is BFS Molecular in?

    BFS Molecular’s primary industry is Outcome Management (Healthcare).

  • Is BFS Molecular a private or public company?

    BFS Molecular is a Private company.

  • What is BFS Molecular’s current revenue?

    The current revenue for BFS Molecular is .

  • Who are BFS Molecular’s competitors?

    Ariel(Decision/Risk Analysis), Congenica, PierianDx, Fabric Genomics, and GenoSpace are some of the 17 competitors of BFS Molecular.

  • When was BFS Molecular acquired?

    BFS Molecular was acquired on 17-Mar-2021.

  • Who acquired BFS Molecular?

    BFS Molecular was acquired by CareDx.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »